215 related articles for article (PubMed ID: 31248601)
1. The use of melatonin in adult psychiatric disorders: Expert recommendations by the French institute of medical research on sleep (SFRMS).
Geoffroy PA; Micoulaud Franchi JA; Lopez R; Schroder CM;
Encephale; 2019 Nov; 45(5):413-423. PubMed ID: 31248601
[TBL] [Abstract][Full Text] [Related]
2. Melatonin (MEL) and its use in circadian rhythm sleep-wake disorders: Recommendations of the French Medical and Research Sleep Society (SFRMS).
Quera-Salva MA; Kilic-Huck U; Vecchierini MF;
Rev Neurol (Paris); 2021 Mar; 177(3):235-244. PubMed ID: 33446328
[TBL] [Abstract][Full Text] [Related]
3. [Sleep disorders in patients with a neurocognitive disorder].
Moderie C; Carrier J; Dang-Vu TT
Encephale; 2022 Jun; 48(3):325-334. PubMed ID: 34916075
[TBL] [Abstract][Full Text] [Related]
4. Role of Melatonin in the Management of Sleep and Circadian Disorders in the Context of Psychiatric Illness.
Moon E; Kim K; Partonen T; Linnaranta O
Curr Psychiatry Rep; 2022 Nov; 24(11):623-634. PubMed ID: 36227449
[TBL] [Abstract][Full Text] [Related]
5. Melatonin (MEL) and its use in neurological diseases and insomnia: Recommendations of the French Medical and Research Sleep Society (SFRMS).
Vecchierini MF; Kilic-Huck U; Quera-Salva MA;
Rev Neurol (Paris); 2021 Mar; 177(3):245-259. PubMed ID: 32921425
[TBL] [Abstract][Full Text] [Related]
6. [How to characterize and treat sleep complaints in bipolar disorders?].
Geoffroy PA; Micoulaud Franchi JA; Lopez R; Poirot I; Brion A; Royant-Parola S; Etain B
Encephale; 2017 Aug; 43(4):363-373. PubMed ID: 27669996
[TBL] [Abstract][Full Text] [Related]
7. International Expert Opinions and Recommendations on the Use of Melatonin in the Treatment of Insomnia and Circadian Sleep Disturbances in Adult Neuropsychiatric Disorders.
Palagini L; Manni R; Aguglia E; Amore M; Brugnoli R; Bioulac S; Bourgin P; Micoulaud Franchi JA; Girardi P; Grassi L; Lopez R; Mencacci C; Plazzi G; Maruani J; Minervino A; Philip P; Royant Parola S; Poirot I; Nobili L; Biggio G; Schroder CM; Geoffroy PA
Front Psychiatry; 2021; 12():688890. PubMed ID: 34177671
[No Abstract] [Full Text] [Related]
8. [Therapeutic approaches for sleep and rhythms disorders in children with ASD].
Schröder CM; Broquère MA; Claustrat B; Delorme R; Franco P; Lecendreux M; Tordjman S
Encephale; 2022 Jun; 48(3):294-303. PubMed ID: 35120753
[TBL] [Abstract][Full Text] [Related]
9. Melatonin and Melatonin Agonists as Adjunctive Treatments in Bipolar Disorders.
Geoffroy PA; Etain B; Franchi JA; Bellivier F; Ritter P
Curr Pharm Des; 2015; 21(23):3352-8. PubMed ID: 26088111
[TBL] [Abstract][Full Text] [Related]
10. [Melatonin: Physiological and pharmacological aspects related to sleep: The interest of a prolonged-release formulation (Circadin
Quera-Salva MA; Claustrat B
Encephale; 2018 Dec; 44(6):548-557. PubMed ID: 30107892
[TBL] [Abstract][Full Text] [Related]
11. [Melatonin--a natural hypnotic?].
Saletu B
Wien Klin Wochenschr; 1997 Oct; 109(18):714-21. PubMed ID: 9441514
[TBL] [Abstract][Full Text] [Related]
12. Melatonin: Physiological effects in humans.
Claustrat B; Leston J
Neurochirurgie; 2015; 61(2-3):77-84. PubMed ID: 25908646
[TBL] [Abstract][Full Text] [Related]
13. Current role of melatonin in pediatric neurology: clinical recommendations.
Bruni O; Alonso-Alconada D; Besag F; Biran V; Braam W; Cortese S; Moavero R; Parisi P; Smits M; Van der Heijden K; Curatolo P
Eur J Paediatr Neurol; 2015 Mar; 19(2):122-33. PubMed ID: 25553845
[TBL] [Abstract][Full Text] [Related]
14. Use of melatonin in the treatment of phase shift and sleep disorders.
Skene DJ; Lockley SW; Arendt J
Adv Exp Med Biol; 1999; 467():79-84. PubMed ID: 10721041
[TBL] [Abstract][Full Text] [Related]
15. Role of the melatonin system in the control of sleep: therapeutic implications.
Pandi-Perumal SR; Srinivasan V; Spence DW; Cardinali DP
CNS Drugs; 2007; 21(12):995-1018. PubMed ID: 18020480
[TBL] [Abstract][Full Text] [Related]
16. Role of melatonin in the regulation of human circadian rhythms and sleep.
Cajochen C; Kräuchi K; Wirz-Justice A
J Neuroendocrinol; 2003 Apr; 15(4):432-7. PubMed ID: 12622846
[TBL] [Abstract][Full Text] [Related]
17. Hypnotic and Melatonin/Melatonin-Receptor Agonist Treatment in Bipolar Disorder: A Systematic Review and Meta-Analysis.
McGowan NM; Kim DS; de Andres Crespo M; Bisdounis L; Kyle SD; Saunders KEA
CNS Drugs; 2022 Apr; 36(4):345-363. PubMed ID: 35305257
[TBL] [Abstract][Full Text] [Related]
18. Bidirectional communication between sleep and circadian rhythms and its implications for depression: lessons from agomelatine.
Pandi-Perumal SR; Moscovitch A; Srinivasan V; Spence DW; Cardinali DP; Brown GM
Prog Neurobiol; 2009 Aug; 88(4):264-71. PubMed ID: 19454302
[TBL] [Abstract][Full Text] [Related]
19. Melatonin: aeromedical, toxicopharmacological, and analytical aspects.
Sanders DC; Chaturvedi AK; Hordinsky JR
J Anal Toxicol; 1999; 23(3):159-67. PubMed ID: 10369324
[TBL] [Abstract][Full Text] [Related]
20. Effects of chronotherapy on circadian rhythm and ADHD symptoms in adults with attention-deficit/hyperactivity disorder and delayed sleep phase syndrome: a randomized clinical trial.
van Andel E; Bijlenga D; Vogel SWN; Beekman ATF; Kooij JJS
Chronobiol Int; 2021 Feb; 38(2):260-269. PubMed ID: 33121289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
